Characteristic | Findings |
---|---|
Number of children enrolled | 100 |
Median age at enrolment in months (range) | 5.52 (1.50-9.93) |
Female, n (%) | 40 (40%) |
Rural residence, n (%) | 76 (76%) |
Number of children who reached four years of age, n (%) | 79 (79%) |
Median years of follow-up (IQR) | 3.46 (3.24-3.66) |
Proportion who reported sleeping under an LLIN* (%) | 3,934/4,008 (98%) |
Antimalarial group children were randomized to, n (%) | Â |
 DP | 51 (51%) |
 AL | 42 (42%) |
 Never randomized | 7 (7%) |
Total incident episodes of malaria** | 1,633 |
 Uncomplicated malaria treated with DP | 847 |
 Uncomplicated malaria treated with AL | 778 |
 Uncomplicated malaria treated with quinine for age <4 months | 2 |
 Quinine for complicated malaria | 6 |
Treatments for malaria within 14 days of prior episode | 12 |
 Quinine for early treatment failure following AL | 5 |
 Quinine for recurrent malaria on day 14 following AL | 2 |
 Quinine/clindamycin for early treatment failure following quinine | 3 |
 Quinine/clindamycin for recurrent malaria days 4–14 following quinine | 2 |
Median malaria incidence through four years of age per person years (IQR) | 5.44 (3.18-7.00) |
Total episodes of asymptomatic parasitaemia | 186 |
Monthly prevalence of asymptomatic parasitaemia | 5.0% |